News
But we will have this information over the next couple of weeks as companies report their Q2 results. Like Batman, we will ...
Pharmaceutical major Wockhardt is targeting a “very healthy bottom line” in the coming quarters, following its exit from the loss-making US generics business, according to the company’s Founder ...
12h
Pharmaceutical Technology on MSNUncertainty around tariffs is a disincentive for pharma onshoring in the USAs tariffs on drug imports from the EU look set to alter pricing and manufacturing strategies, each entity needs to study its full impact.
15hOpinion
Zacks Investment Research on MSN4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff RisksThe Zacks Medical - Dental Supplies industry in the Medical sector is reflecting weakness amid rising tariffs by the U.S.
Few major trading partners have been spared the import taxes, which have already disrupted supply chains and are expected to ...
So far, however, there are signs of self-inflicted wounds to the U.S. as companies and consumers brace for the impact of the ...
The Trump administration’s sweeping new tariffs of up to 50% are reshaping global trade. See how Australia and Greece are ...
American businesses and consumers soon will have a better idea of how President Donald Trump’s foreign trade agenda might ...
How could higher U.S. tariffs on Indian pharmaceutical products impact drug stocks? Seeking Alpha analysts weigh in. Read ...
The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere in ...
The U.S. has begun officially levying higher taxes on imports from dozens of countries Thursday, four months after President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results